IMATINIB MESYLATE 100 MG TAB

Imatinib
$0.8838per EA

Strength

100 mg/1

NDC

43598034490

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

5/21/2025

Active Ingredients

IMATINIB MESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA206547

On Market Since

8/13/2018

Pharmacological Classes

Bcr-Abl Tyrosine Kinase Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Kinase Inhibitor

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+7.4%

3Y

+45.2%

5Y

-71.8%

All

-85.5%